1887

Journal of Medical Microbiology logo

Volume 62, Issue 7

Community spread of extended-spectrum β-lactamase-producing , and : a long-term study in Japan Free

Abstract

Community-acquired infections caused by extended-spectrum β-lactamase (ESBL)-producing bacteria, particularly CTX-M-producing , are a rising concern worldwide. There are few data from Japan on the acquisition of ESBLs in the community or the influx of these bacteria into hospitals. Therefore, we examined the prevalence of ESBL carriage in outpatients, in order to estimate the spread of ESBLs in community settings. We analysed bacterial isolates from outpatient samples at our institution over a 9-year period from 2003 to 2011, with respect to epidemiological data on ESBL-producing bacteria and their genotypic features. Out of 5137 isolates, 321 (6.3 %) were ESBL producers, including , and . The detection rates of the ESBL-producing isolates gradually increased and reached 14.3, 8.7 and 19.6 % for , and strains, respectively, in 2011. Genotyping analysis showed that many of the strains produced multiple β-lactamases, including TEM, SHV and CTX-M, rather than just CTX-M. The CTX-M-9 group was dominant among the CTX-M genotypes; further, the CTX-M-1 and M-2 groups were also detected (~30 %). This is believed to be the first report from Japan showing a definite increase in ESBL detection in outpatients. In addition, our findings suggest the simultaneous community spread of diverse ESBL genotypes, not an expansion of particular ESBL genes.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.059279-0
2013-07-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/7/1038.html?itemId=/content/journal/jmm/10.1099/jmm.0.059279-0&mimeType=html&fmt=ahah

References

  1. Ben-Ami R., Schwaber M. J., Navon-Venezia S., Schwartz D., Giladi M., Chmelnitsky I., Leavitt A., Carmeli Y. 2006; Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934 [View Article][PubMed]
     [Google Scholar]
  2. Bonnet R. 2004; Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14 [View Article][PubMed]
     [Google Scholar]
  3. Calbo E., Freixas N., Xercavins M., Riera M., Nicolás C., Monistrol O., Solé M. M., Sala M. R., Vila J., Garau J. 2011; Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 52:743–749 [View Article][PubMed]
     [Google Scholar]
  4. Cantón R., Coque T. M. 2006; The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9:466–475 [View Article][PubMed]
     [Google Scholar]
  5. Chong Y., Yakushiji H., Ito Y., Kamimura T. 2011; Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 30:83–87 [View Article][PubMed]
     [Google Scholar]
  6. Falagas M. E., Kastoris A. C., Kapaskelis A. M., Karageorgopoulos D. E. 2010; Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43–50 [View Article][PubMed]
     [Google Scholar]
  7. Hansen D. S., Schumacher H., Hansen F., Stegger M., Hertz F. B., Schønning K., Justesen U. S., Frimodt-Møller N.DANRES Study Group 2012; Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis 44:174–181 [View Article][PubMed]
     [Google Scholar]
  8. Hawkey P. M. 2008; Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 14:Suppl. 1159–165 [View Article][PubMed]
     [Google Scholar]
  9. Ishii Y., Ohno A., Taguchi H., Imajo S., Ishiguro M., Matsuzawa H. 1995; Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39:2269–2275 [View Article][PubMed]
     [Google Scholar]
  10. Jacoby G. A., Munoz-Price L. S. 2005; The new beta-lactamases. N Engl J Med 352:380–391 [View Article][PubMed]
     [Google Scholar]
  11. Khanna N., Boyes J., Lansdell P. M., Hamouda A., Amyes S. G. 2012; Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 67:573–577 [View Article][PubMed]
     [Google Scholar]
  12. Lee J. A., Kang C. I., Joo E. J., Ha Y. E., Kang S. J., Park S. Y., Chung D. R., Peck K. R., Ko K. S. et al. 2011; Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 17:267–273 [View Article][PubMed]
     [Google Scholar]
  13. Luvsansharav U. O., Hirai I., Niki M., Nakata A., Yoshinaga A., Moriyama T., Yamamoto Y. 2011; Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 17:722–725 [View Article][PubMed]
     [Google Scholar]
  14. Luzzaro F., Mezzatesta M., Mugnaioli C., Perilli M., Stefani S., Amicosante G., Rossolini G. M., Toniolo A. 2006; Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44:1659–1664 [View Article][PubMed]
     [Google Scholar]
  15. Muratani T., Kobayashi T., Matsumoto T. 2006; Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int J Antimicrob Agents 27:491–499 [View Article][PubMed]
     [Google Scholar]
  16. Oteo J., Orden B., Bautista V., Cuevas O., Arroyo M., Martínez-Ruiz R., Pérez-Vázquez M., Alcaraz M., García-Cobos S., Campos J. 2009; CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J Antimicrob Chemother 64:712–717 [View Article][PubMed]
     [Google Scholar]
  17. Oteo J., Pérez-Vázquez M., Campos J. 2010; Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23:320–326 [View Article][PubMed]
     [Google Scholar]
  18. Paterson D. L., Bonomo R. A. 2005; Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18:657–686 [View Article][PubMed]
     [Google Scholar]
  19. Peirano G., Pitout J. D. 2010; Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25 : H4. Int J Antimicrob Agents 35:316–321 [View Article][PubMed]
     [Google Scholar]
  20. Pitout J. D., Laupland K. B. 2008; Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166 [View Article][PubMed]
     [Google Scholar]
  21. Reinert R. R., Low D. E., Rossi F., Zhang X., Wattal C., Dowzicky M. J. 2007; Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60:1018–1029 [View Article][PubMed]
     [Google Scholar]
  22. Rodríguez-Baño J., Navarro M. D., Romero L., Muniain M. A., de Cueto M., Ríos M. J., Hernández J. R., Pascual A. 2006; Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 43:1407–1414 [View Article][PubMed]
     [Google Scholar]
  23. Rodríguez-Baño J., Picón E., Gijón P., Hernández J. R., Ruíz M., Peña C., Almela M., Almirante B., Grill F. et al. 2010; Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50:40–48 [View Article][PubMed]
     [Google Scholar]
  24. Rossi F., Baquero F., Hsueh P. R., Paterson D. L., Bochicchio G. V., Snyder T. A., Satishchandran V., McCarroll K., DiNubile M. J., Chow J. W. 2006; In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (study for monitoring antimicrobial resistance trends). J Antimicrob Chemother 58:205–210 [View Article][PubMed]
     [Google Scholar]
  25. Roux D., Huy C., Lolom I., Andremont A., Arlet G., Armand-Lefevre L., Lucet J. C. 2012; Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission. Scand J Infect Dis 44:231–236 [View Article][PubMed]
     [Google Scholar]
  26. Shibata N., Kurokawa H., Doi Y., Yagi T., Yamane K., Wachino J., Suzuki S., Kimura K., Ishikawa S. et al. 2006; PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 50:791–795 [View Article][PubMed]
     [Google Scholar]
  27. Soge O. O., Queenan A. M., Ojo K. K., Adeniyi B. A., Roberts M. C. 2006; CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 57:24–30 [View Article][PubMed]
     [Google Scholar]
  28. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y. 2009; Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63:72–79 [View Article][PubMed]
     [Google Scholar]
  29. Talbot G. H., Bradley J., Edwards J. E. Jr, Gilbert D., Scheld M., Bartlett J. G.Antimicrobial Availability Task Force of the Infectious Diseases Society of America 2006; Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42:657–668 [View Article][PubMed]
     [Google Scholar]
  30. Tumbarello M., Trecarichi E. M., Bassetti M., De Rosa F. G., Spanu T., Di Meco E., Losito A. R., Parisini A., Pagani N., Cauda R. 2011; Identifying patients harboring extended-spectrum-β-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 55:3485–3490 [View Article][PubMed]
     [Google Scholar]
  31. Valverde A., Coque T. M., García-San Miguel L., Baquero F., Cantón R. 2008; Complex molecular epidemiology of extended-spectrum β-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother 61:64–72 [View Article][PubMed]
     [Google Scholar]
  32. Woerther P. L., Angebault C., Lescat M., Ruppé E., Skurnik D., Mniai A. E., Clermont O., Jacquier H., Costa A. D. et al. 2010; Emergence and dissemination of extended-spectrum β-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 202:515–523 [View Article][PubMed]
     [Google Scholar]
  33. Woerther P. L., Angebault C., Jacquier H., Hugede H. C., Janssens A. C., Sayadi S., El Mniai A., Armand-Lefèvre L., Ruppé E. et al. 2011; Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 53:677–685 [View Article][PubMed]
     [Google Scholar]
  34. Yamaguchi K., Ishii Y., Iwata M., Watanabe N., Shinagawa M., Yasujima M., Suwabe A., Kuroda M., Kaku M. et al. 2011; Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009. Jpn J Antibiot 64:53–95 (in Japanese) [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.059279-0
Loading
Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan
J. Med. Microbiol. 62, 1038 (2013); https://doi.org/10.1099/jmm.0.059279-0
/content/journal/jmm/10.1099/jmm.0.059279-0
/content/journal/jmm/10.1099/jmm.0.059279-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error